Home / Companies / Interviews / GSK to bring Herpes Zoster vaccine Shingrix at one-third of US price: MD

GSK to bring Herpes Zoster vaccine Shingrix at one-third of US price: MD

Shingrix is for the prevention of shingles or what is also known as herpes zoster and also post-herpetic neuralgia in people aged 50 and above, says GSK Pharmaceuticals MD Bhushan Akshikar

Premium

Bhushan Akshikar, MD, GSK Pharmaceuticals

Sohini Das Mumbai

4 min read Last Updated : Apr 24 2023 | 7:45 PM IST

Listen to This Article

GlaxoSmithKline Pharmaceuticals, launched the Herpes Zoster vaccine named Shingrix on Monday, is now focusing on adult vaccination in the country. GSK Pharmaceuticals MD Bhushan Akshikar talks to Sohini Das about the company’s India plans. Edited excerpts:

Why is it important to take the Shingles (Herpes Zoster) vaccine for adults?

Shingrix (Zoster vaccine recombinant) is for the prevention of shingles or what is also known as herpes zoster and also post-herpetic neuralgia in people aged 50 and above. It’s the world’s first non-live recombinant subunit vaccine administered through the intramuscular route in two doses.

Shingles is caused by re-activation of the

Topics : Q&A GSK Vaccine Q&A with GSK Pharma MD

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in